Publication type: | Article in scientific journal |
Type of review: | Peer review (publication) |
Title: | Medizin und Ökonomie - Freunde oder Feinde? |
Authors: | Brügger, Urs |
DOI: | 10.1024/0040-5930/a000864 |
Published in: | Therapeutische Umschau |
Volume(Issue): | 74 |
Issue: | 1 |
Page(s): | 777 |
Pages to: | 785 |
Issue Date: | 2017 |
Publisher / Ed. Institution: | Hogrefe |
ISSN: | 0040-5930 1664-2864 |
Language: | German |
Subject (DDC): | 362.1041: Health economics |
Abstract: | The healthcare sector is booming. In many areas the Swiss health system tends to provide excessive medical care and, thus, generates overuse and waste. In others however, medical care is insufficient. “Economisation” is often blamed for both misdevelopments. People talk about false incentives and commodification, but they also talk about excessive savings and rationing. Health is not a commodity like any other. It is, beyond any doubt, one of the most important goods. There are good economic reasons why health care is not left to the free market. In order for the system to work without a market mechanism, economic tools, such as health-economic evaluations and tariffs are needed. It is of great importance which medical services are reimbursed and how high the reimbursement is. Unfortunately, these tools have also undesirable side effects. Medical services should primarily focus on the medical necessity, not on economic interests. “Indication quality” is an essential condition to avoid excessive, insufficient or inappropriate medical care. Secondly, the care providers must offer efficient services. This is why approaches such as “lean management”, which have long been used in other industries, have found their way into the healthcare sector. “Value” is only created in the healthcare sector if patients receive the appropriate medical care, and if the medical care, and if those services are provided in an efficient way. Only then the criteria of “effectiveness, appropriateness and cost-effectiveness”, stipulated by the Health Insurance law for the reimbursement of services are fulfilled. This is in the interest of both patients and society as well well as in the spirit of medicine and economics. |
URI: | https://digitalcollection.zhaw.ch/handle/11475/15914 |
Fulltext version: | Published version |
License (according to publishing contract): | Licence according to publishing contract |
Departement: | School of Management and Law |
Appears in collections: | Publikationen School of Management and Law |
Files in This Item:
There are no files associated with this item.
Show full item record
Brügger, U. (2017). Medizin und Ökonomie - Freunde oder Feinde? Therapeutische Umschau, 74(1), 777–785. https://doi.org/10.1024/0040-5930/a000864
Brügger, U. (2017) ‘Medizin und Ökonomie - Freunde oder Feinde?’, Therapeutische Umschau, 74(1), pp. 777–785. Available at: https://doi.org/10.1024/0040-5930/a000864.
U. Brügger, “Medizin und Ökonomie - Freunde oder Feinde?,” Therapeutische Umschau, vol. 74, no. 1, pp. 777–785, 2017, doi: 10.1024/0040-5930/a000864.
BRÜGGER, Urs, 2017. Medizin und Ökonomie - Freunde oder Feinde? Therapeutische Umschau. 2017. Bd. 74, Nr. 1, S. 777–785. DOI 10.1024/0040-5930/a000864
Brügger, Urs. 2017. “Medizin und Ökonomie - Freunde oder Feinde?” Therapeutische Umschau 74 (1): 777–85. https://doi.org/10.1024/0040-5930/a000864.
Brügger, Urs. “Medizin und Ökonomie - Freunde oder Feinde?” Therapeutische Umschau, vol. 74, no. 1, 2017, pp. 777–85, https://doi.org/10.1024/0040-5930/a000864.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.